Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder – BioSpace

Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder  BioSpace

Purim Shpiel: New cutting-edge weight loss procedure takes the world by storm – The Jerusalem Post

Purim Shpiel: New cutting-edge weight loss procedure takes the world by storm  The Jerusalem Post

Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players – University of Illinois Urbana-Champaign

Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players  University of Illinois Urbana-Champaign

DPP4 and GLP-1: The Dynamic Duo in Diabetes Management

Dipeptidyl peptidase-4 (DPP4) is an enzyme that plays a crucial role in glucose metabolism and the…

Video FBI warns about counterfeit weight loss drugs – ABC News

Video FBI warns about counterfeit weight loss drugs  ABC News

Healthy Eating: GLP-1 Diet for Celebs

**Title: The GLP-1 Diet: A Celebrity Trend Transforming Health and Wellness** **The GLP-1 diet is rooted…

MeiraGTx and Hologen launch AI-backed gene therapy venture

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to…

6 common weight loss myths busted: Expert explains the reasoning behind popular claims – Hindustan Times

6 common weight loss myths busted: Expert explains the reasoning behind popular claims  Hindustan Times

Weight Loss Isn’t Always Healthy? Study Finds It Can Be Deadly for Some Patients – SciTechDaily

Weight Loss Isn’t Always Healthy? Study Finds It Can Be Deadly for Some Patients  SciTechDaily

EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia

The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic, Rxulti (brexpiprazole), for treating schizophrenia.